InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU), a leading national health care service provider, has announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, before the market opens. The company will host a conference call at 9:00 a.m. Eastern Time on the same day to discuss the results.
InfuSystem operates under a two-platform model: Patient Services, which includes Oncology, Pain Management, and Wound Therapy businesses, and Device Solutions, which supports Patient Services and focuses on direct payer clients. The company provides outpatient care solutions for durable medical equipment manufacturers and health care providers, with a focus on clinic-to-home healthcare for complex treatments.
InfuSystem Holdings, Inc. (NYSE American: INFU), un importante fornitore nazionale di servizi sanitari, ha annunciato che pubblicherà i suoi risultati finanziari del secondo trimestre 2024 il giovedì 8 agosto 2024, prima dell'apertura del mercato. L'azienda organizzerà una conference call alle 9:00 a.m. Eastern Time lo stesso giorno per discutere i risultati.
InfuSystem opera sotto un modello a due piattaforme: Servizi ai Pazienti, che include oncologia, gestione del dolore e terapia delle ferite, e Soluzioni Dispositivo, che supporta i Servizi ai Pazienti e si concentra su clienti pagatori diretti. L'azienda fornisce soluzioni di assistenza ambulatoriale per produttori di attrezzature mediche durevoli e fornitori di servizi sanitari, con un focus sull'assistenza sanitaria clinic-to-home per trattamenti complessi.
InfuSystem Holdings, Inc. (NYSE American: INFU), un importante proveedor nacional de servicios de salud, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el jueves 8 de agosto de 2024, antes de la apertura del mercado. La compañía organizará una conferencia telefónica a las 9:00 a.m. Eastern Time el mismo día para discutir los resultados.
InfuSystem opera bajo un modelo de dos plataformas: Servicios para Pacientes, que incluye oncología, manejo del dolor y terapia de heridas, y Soluciones de Dispositivos, que apoya a los Servicios para Pacientes y se enfoca en clientes pagadores directos. La empresa ofrece soluciones de atención ambulatoria para fabricantes de equipos médicos duraderos y proveedores de atención médica, con un enfoque en la atención médica de clínica a hogar para tratamientos complejos.
InfuSystem Holdings, Inc. (NYSE American: INFU)는 주요 국가 건강 관리 서비스 제공업체로서 2024년 2분기 재무 실적을 2024년 8월 8일 목요일에 시장 개장 전에 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오전 9시에 결과에 대해 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다.
InfuSystem은 환자 서비스와 장치 솔루션의 두 가지 플랫폼 모델을 운영합니다. 환자 서비스에는 종양학, 통증 관리 및 상처 치료 비즈니스가 포함되고, 장치 솔루션은 환자 서비스를 지원하며 직접 지불 고객에 중점을 둡니다. 이 회사는 내구성 있는 의료 장비 제조업체와 의료 제공자를 위한 외래 치료 솔루션을 제공하며, 복잡한 치료를 위한 클리닉-투-홈 헬스케어에 집중하고 있습니다.
InfuSystem Holdings, Inc. (NYSE American: INFU), un fournisseur national de services de santé de premier plan, a annoncé qu'il publiera ses résultats financiers du deuxième trimestre 2024 le jeudi 8 août 2024, avant l'ouverture du marché. L'entreprise organisera une conférence téléphonique à 9h00, heure de l'Est le même jour pour discuter des résultats.
InfuSystem opère selon un modèle à deux plateformes : Services aux Patients, qui comprend les secteurs de l'oncologie, de la gestion de la douleur et de la thérapie des plaies, et Solutions de Dispositifs, qui soutient les Services aux Patients et se concentre sur les clients payeurs directs. L'entreprise propose des solutions de soins ambulatoires pour les fabricants d'équipements médicaux durables et les prestataires de soins de santé, avec un accent sur les soins de santé de la clinique à domicile pour des traitements complexes.
InfuSystem Holdings, Inc. (NYSE American: INFU), ein führender nationaler Anbieter von Gesundheitsdiensten, hat bekannt gegeben, dass es seine Finanzergebnisse für das zweite Quartal 2024 am Donnerstag, den 8. August 2024, vor Markteröffnung veröffentlichen wird. Das Unternehmen wird am selben Tag um 9:00 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
InfuSystem arbeitet nach einem Zwei-Plattform-Modell: Patientendienste, zu dem Onkologie, Schmerzmanagement und Wundtherapiebereiche gehören, sowie Gerätesolutions, die die Patientendienste unterstützt und sich auf direkte Zahler konzentriert. Das Unternehmen bietet Lösungen für die ambulante Versorgung für Hersteller von langlebigen medizinischen Geräten und Gesundheitsdienstleister an, mit einem Fokus auf die Klinik-zu-Haus-Gesundheitsversorgung bei komplexen Behandlungen.
- None.
- None.
Investor Conference Call to be held 9:00 a.m. Eastern Time
The Company will also conduct a conference call for all interested parties on Thursday, August 8, 2024 at 9:00 a.m. Eastern Time to discuss its financial results.
To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in the Investors section of the Company’s website at https://ir.infusystem.com/. A replay of the call will be available by visiting https://ir.infusystem.com/ for the next 90 days or by calling (877) 344-7529 or (412) 317-0088, replay access code 6530466 through Thursday, August 15, 2024.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The lead platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240802708310/en/
Joe Dorame, Joe Diaz & Robert Blum
Lytham Partners, LLC
602-889-9700
Source: InfuSystem Holdings, Inc.
FAQ
When will InfuSystem (INFU) release its Q2 2024 financial results?
What time is InfuSystem's (INFU) Q2 2024 earnings conference call?
How can investors participate in InfuSystem's (INFU) Q2 2024 earnings call?
What are the main business segments of InfuSystem (INFU)?
